Black technology, starting from daily check-in

Chapter 95 List of urgently needed new drugs in clinical practice

July 7st, around seven in the morning.

In the high-level VIP ward, chaotic and dazzling light spots shone in from the window and reflected on the polished marble tiles, completely illuminating the dark room.

On the white hospital bed, Lin Yu lay quietly on it, with his eyes closed and his breathing steady. In his deep sleep, he gave people an inexplicable sense of beauty like an ancient Greek sculpture.

And beside the white hospital bed, Su Muyun held his hand tightly, lying on the bed and slowly falling asleep.

Time passed slowly, and the sun gradually rose. A large piece of dazzling bright sunlight moved slowly from the polished tiles, and finally shone through the window on Lin Yu's closed eyes.

Under the dazzling sunlight, at a certain moment, Lin Yu's eyes trembled slightly on the hospital bed, and then slowly opened them.

Immediately, the dazzling sunlight coming in from the window made him subconsciously squint his eyes slightly.

"Is this... in the hospital?"

After waking up, looking at the surrounding environment, Lin Yu also came back to his senses.

But soon, he noticed Su Muyun who was sleeping on the hospital bed while holding his hand.

Seeing her frowning in deep sleep, Lin Yu subconsciously wanted to help her smooth her brows, but found that his left hand seemed to have a needle in it.

He couldn't help but turned around and looked up, and found that the injection was glucose, but it had already been administered.

At the same time, Lin Yu's weak movement made Su Muyun, who was already in a light sleep, wake up instantly.

"Honey, you're awake, do you need me to call the doctor?" Seeing Lin Yu looking at the empty bottle on his head, Su Muyun quickly got up and asked.

"It's okay, no need."

Seeing that Su Muyun had woken up, Lin Yu smiled slightly, and immediately removed the needle in his left hand skillfully, and pressed it with his hand to stop the bleeding with his bare hands.

After doing all this, he couldn't help looking at Su Muyun, and said with a smile: "I don't have any serious problems, I'm just a little tired yesterday."

When he saw Su Muyun sleeping, he knew it should be the next day.

It can be said that he slept directly from yesterday afternoon to this morning, sleeping for more than ten hours.

It’s okay if Lin Yu didn’t say this, but Su Muyun rolled his eyes when he said it, and said angrily and helplessly: “After you successfully developed the neuroma antibody yesterday, you should eat and rest well, and you can do the rest. It can be handed over to other people to complete, why are you working so hard, really."

After she received a call from the hospital yesterday afternoon, she was frightened silly by the news that Lin Yu had fainted.

Fortunately, the doctor at the time said that he was just overtired, coupled with not eating, and his body function reached its limit, so he fainted.

Otherwise, Su Muyun thought that Lin Yu had done something important again, and then got seriously injured and fainted.

Listening to the complaints in Su Muyun's words, Lin Yu just smiled softly and didn't say anything.

He naturally knew that what Su Muyun said was right, but he had to do what happened yesterday by himself.

Because he had missed the regret of saving Xiao Yi before, so he must not miss the regret of saving Xiao Yi again.

Seeing Lin Yu's smirk and silence, Su Muyun couldn't help but snorted, and then asked, "Are you hungry? I'll prepare something for you if you want to eat."

Just when Lin Yu was about to answer with a smile on his face, the door of the room was suddenly opened. A doctor walked in with several nurses, and behind them were Ouyang Lei and Yuan Cong.

After realizing that someone was coming in, Lin Yu and Su Muyun subconsciously followed the prestige.

After a group of people came in, the middle-aged doctor who was the leader looked at Lin Yu who had pulled out the needle by himself, and asked gently, "Mr. Lin, how do you feel?"

"Well, not bad."

Lin Yu nodded, and immediately seemed to think of something, and asked quickly: "How is Xiao Yi's condition, should his adverse reaction period have passed?"

Before the doctor could speak, Yuan Cong, who was following behind him, replied excitedly: "It's over, it's over, after Xiao Yi had a fever and hallucinations last night, he woke up this morning , and also ate a big bowl of porridge and a drawer of steamed buns, looking very good!"

Hearing this, Lin Yu couldn't help showing a gratified smile on his face: "That's good, the antibody shot I gave him is only a course of treatment, and I need to take a few more shots, basically it can completely relieve the neurosis in his body." Cell tumor."

"If there are no accidents, then in the next five years, the chance of him getting sick again will be very small."

Hearing this, the doctor on the side also nodded, and said: "Yes, after our examination, we found that the solid tumor in his body has been greatly reduced. If we continue to follow this speed of remission, he will be able to recover soon." get well."

Speaking of this, the doctor couldn't help looking at Lin Yu, and asked sincerely: "Mr. Lin, when will this neuroblastoma antibody be available on the market? There are still many children with neuroblastoma who are very sick." This medicine is needed."

"I don't know when it will be launched, and, with all due respect, the production of this new neuroma antibody agent is currently very small."

"Because the technology it needs is quite complicated. This is a combination derived from my CAR-T cell immunotherapy, so now basically no one can do it except me." Lin Yu pondered for a moment After that, he said slowly.

Traditional CAR-T cell immunotherapy needs to extract the patient's cells, and then carry out subsequent genetic engineering modification, expansion, reinfusion, and reinfusion stages.

Not only is it time-consuming and labor-intensive, but the most important thing is that it is only for the patient.

But now, the brand-new neuroma antibody developed by Lin Yu doesn’t need to be so troublesome. It can directly transform the supply chain of “extraction-modification-reinfusion” of autologous CAR-T cells into the off-the-shelf supply chain of traditional drugs.

In other words, CAR-T cell immunotherapy is only for individuals, while this new neurotumor immunotherapy is for all neuroma patients.

In fact, in a sense, the neuroma immunotherapy developed by Lin Yu is stronger than CAR-T cell immunotherapy.

Because Lin Yu only needs to teach this technology to others, then he can quickly realize large-scale supply.

Compared with CAR-T cell technology, which is personalized and customized, and cannot be supplied on a large scale, this is undoubtedly more convenient and faster, and it is more affordable for ordinary people.

After all, CAR-T cell immunotherapy, which is customized by a person, is not something ordinary people can afford.

After listening to what Lin Yu said, the doctor couldn't help but sigh with regret.

Seeing this, Ouyang Lei who had been standing behind suddenly said: "Chairman, I forgot to tell you that after you fainted yesterday, we spread the news of the successful development of neuroma immunotherapy. Moreover, this new type of anticancer drug has also been included in the list of clinically urgently needed new drugs by the state."

For this good news, not only the doctor, but even Lin Yu's eyes light up.

Being included in the list of urgently needed new drugs in clinical practice means that it has the fast-track approval qualification from the China Drug Administration.

This is just like the last time Lin Yu developed China's first anti-cancer drug. As long as they realize the large-scale production of the drug, it can be said that the launch is just around the corner.

Thinking of this, Lin Yu's already decided idea suddenly became more firm.

Antibody agents for neuroblastoma must be scaled up as soon as possible!

Tap the screen to use advanced tools Tip: You can use left and right keyboard keys to browse between chapters.

You'll Also Like